Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II)

S Zeuzem, R Flisiak, J M Vierling, W Mazur, G Mazzella, S Thongsawat, D Abdurakhmanov, N Van Kính, P Calistru, J Heo, C Stanciu, M Gould, M Makara, S-J Hsu, P Buggisch, D Samuel, D Mutimer, B Nault, M Merz, W BaoL H Griffel, C Brass, N V Naoumov, ESSENTIAL II Study Group

Research output: Contribution to journal › Article › peer-review

29 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II)'. Together they form a unique fingerprint.

Medicine & Life Sciences